Overview

Safety and Efficacy of ZP-Glucagon to Injectable Glucagon for Hypoglycemia

Status:
Completed
Trial end date:
2015-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether glucagon administered by microneedle patch is comparable to glucagon administered by injection pen in the treatment of insulin-induced hypoglycemia.
Phase:
Phase 1
Details
Lead Sponsor:
Zosano Pharma Corporation
Zosano Pharma Inc.
Treatments:
Glucagon
Glucagon-Like Peptide 1